CeriBell (CBLL) said Wednesday its point-of-care electroencephalogram system has received full Federal Risk & Authorization Management Program, or FedRAMP, High authorization from the US government, which is granted to organizations that meet the highest cybersecurity standards.

The company said the designation allows its solution to be adopted across federal healthcare systems, expanding access to rapid diagnosis of non-convulsive seizures, particularly for US veterans and other high-risk patients.

Shares of CeriBell were down 3.4% in recent trading.

Price: 15.81, Change: -0.55, Percent Change: -3.36